Rising prevalence of neglected tropical diseases (NTDs) worldwide coupled with growing demand for advanced rabies diagnostic solutions to boost market growth
Rabies Diagnostics Market Size – USD 1.69 billion in 2020, Industry Growth – at a CAGR of 4.4%, Trends – Rising initiatives to develop novel rabies detection assays
The global rabies diagnostics market size is expected to reach USD 2.38 billion by 2028 at a CAGR of 4.4% according to the latest report by Reports and Data. The most critical parameters influencing the global market growth are rising prevalence of infectious animal-transmitted diseases such as rabies and neglected tropical diseases (NTDs) worldwide, increasing awareness programs about infectious diseases, and growing number of rabies diagnostic tests.
Rabies is an infectious disease spread through animal bite or saliva and is characterized by symptoms such as excess salivation, headache, fever, muscle spasms, and mental instability. The most commonly known rabies diagnostic methods include Direct Fluorescent Antibody (DFA) test, Fluorescent Antibody Test (FAT), immunohistochemical tests, and amplification methods. These tests rapidly and accurately detect rabies virus antigens in brain tissue. Rabies diagnostic tests are generally performed using samples of bodily fluids such as saliva, serum, and spinal fluid of the infected person. Growth of the global rabies diagnostics market is propelled by rising adoption of advanced diagnostic solutions for rabies, increasing collaborations among research institutes and healthcare companies for the development of novel rabies detection assays, and increase in initiatives undertaken by healthcare organizations to control the spread of rabies. Growing adoption of cutting-edge point-of-care rabies diagnostic solutions worldwide is another major growth-inducing factor for this market.
Merck KGaA, Bio-Rad Laboratories, Inc., Norgen Biotek Corp., Express Biotech International Inc., Demeditec Diagnostics GmbH, Aviva Systems Biology Corporation, BioGen Technologies, Creative Diagnostics, MyBioSource.com, Abbexa Ltd., and BioNote, Inc. are among the leading competitors of the global rabies diagnostics
Get a Free Sample now@ https://www.reportsanddata.com/sample-enquiry-form/4037
For the purpose of this report, the global rabies diagnostics market has been segmented based on the product type, test type, end-user, and region:
By Diagnostic Method (Revenue, USD Billion; 2018-2028)
By Technology Type (Revenue, USD Billion; 2018-2028)
Quick buy@ https://www.reportsanddata.com/checkout-form/4037
By Provider (Revenue, USD Billion; 2018-2028)
By Region (Revenue, USD Billion; 2018-2028)
Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/4037
Key Highlights of the Report:
Table of Content:
Chapter 1 Rabies Diagnostics Market: Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased database
1.4.2 Internal database
1.4.3 Secondary sources
1.4.4 Primary Research
1.5 Information or Data Analysis
1.5.1 Data analysis models
1.6 Market Formulation & Validation
1.7 Objectives
1.6.1 Objective 1
1.6.2 Objective 2
Chapter 2 Rabies Diagnostics Market: Executive Summary
2.1 Market Summary, 2021
Chapter 3 Rabies Diagnostics Market: Industry Outlook
3.1 Industry Pyramid Analysis
3.2 Market Segmentation & Scope
3.2.1 Market drivers analysis
Continue…
Request for customization@ https://www.reportsanddata.com/request-customization-form/4037
Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Read More Reports:
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com